ArticleJAMA network open2021

Clinical Response to Immunotherapy Targeting Programmed Cell Death Receptor 1/Programmed Cell Death Ligand 1 in Patients With Treatment-Resistant Microsatellite Stable Colorectal Cancer With and Without Liver Metastases.

Chongkai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.